GCM
NBSE

Glenview Capital Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Glenview Capital Management’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,000
Closed -$739K – 71
2021
Q1 		$739K Buy
+5,000
New +$739K 0.01% 62